2020 Insights into Sleep Aids in India – Impact of COVID-19 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Sleep Aids in India” report has been added to ResearchAndMarkets.com’s offering.

Sales of sleep aids are negligible in India. Consumers prefer to visit a doctor and receive prescription products for sleep-related issues instead of self-medicating. Hence, the availability and consumption of OTC sleep aids is very low.

The Sleep Aids in India report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Sleep Aids market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Key Topics Covered:

2020 IMPACT

EXECUTIVE SUMMARY

• COVID-19 impact on consumer health
• COVID-19 country impact
• Company response
• Retailing shift
• What next for consumer health?

MARKET INDICATORS

• Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
• Table 2 Life Expectancy at Birth 2015-2020

MARKET DATA

• Table 3 Sales of Consumer Health by Category: Value 2015-2020
• Table 4 Sales of Consumer Health by Category: % Value Growth 2015-2020
• Table 5 NBO Company Shares of Consumer Health: % Value 2016-2020
• Table 6 LBN Brand Shares of Consumer Health: % Value 2017-2020
• Table 7 Distribution of Consumer Health by Format: % Value 2015-2020
• Table 8 Distribution of Consumer Health by Format and Category: % Value 2020
• Table 9 Forecast Sales of Consumer Health by Category: Value 2020-2025
• Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025

APPENDIX

• OTC registration and classification
• Vitamins and dietary supplements registration and classification
• Self-medication/self-care and preventive medicine

For more information about this report visit https://www.researchandmarkets.com/r/1pjmic

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900